Association of T352C and A16974C polymorphisms with lepromatose leprosy in Cuban patients
Abstract
Introduction: Leprosy is an infectious disease caused by Mycobacterium leprae. Dermatoglyphic patterns of Cuban patients with lepromatose leprosy showed evidential signs of the existence of genetic predisposition to the development of this disease, which suggests a search for the association with molecular polymorphisms of higher degree of accuracy. Among them, some of the most studied are the T352C vitamin D receptor gene and the A16974Cof the IL12p40 gene, which relative usefulness depends on the population.
Objective:To determine whether there is an association between the T352Cand A16974C polymorphisms with lepromatose leprosy in Cuban patients.
Material and methods:An observational analytical case-control type genetic association study was conducted where patients with lepromatose leprosy and controls were studied. Genotypes related to T352Cand A16974C polymorphisms were identified in each group. Pearson´s chi square test was used to determine whether the controls were in Hardy-Weinberg equilibrium, and also whether there was a relation between polymorphisms and the presence of diseases.
Results: There were 32 patients under study for T352C polymorphism, and 42 for A16974C. The controls were 64 and 44, respectively; and these were in Hardy-Weinberg equilibrium. No association between T352Cand A16974C polymorphisms with lepromatose leprosy was detected.
Conclusions: T352Cand A16974C polymorphisms are not useful as a predisposing risk factor in the group of Cuban patients with lepromatose leprosy studied.
Keywords: Leprosy, genetic polymorphism, genetic predisposition to disease, Cuba, Hardy-Weinberg equilibrium, alleles.
Downloads
References
1.-Gil SR, Hernández GO, Rojas V. Programa de control de lepra para el médico de la familia. 2da. ed. La Habana: Editorial Ciencias Médicas; 1994.p.1
2.-Alonso Gómez M E, Santin Peña M, Abreu Daniel A, Lobio Cárdenas Z. Peson Hernández O, Suárez Moreno O, et al .Lepra Normas Técnicas para el control y tratamiento. Ciudad de la Habana: Ed Ciencias Médicas. 2008;7-18.
3.-Beldarraín-Chaple E. Historical Overview of Leprosy Control in Cuba. MEDICC Rev. 2017 Jan;19 (1):23-30
4.-Motta PM, Cech N, Fontan C, Giménez MF, Lodeiro N, Marinic K, Molinari ML, Sotelo MG, Habegger de Sorrentino A. Papel de las moléculas HLA-DR y HLA-DQ en la lepra multibacilar y paucibacilar en la provincia del Chaco; Argentina. Enferm Infecc Microbiol Clin. 2007 Dec;25 (10):627-31.
5.-Trautman J. A brief history of Hansen's disease . The start 1990 [citado 2 de Mayo 2017] ;50: 3-5 Disponible en: http://cdm16313.contentdm.oclc.org/cdm/compoundobject/collection/p15140coll52/id/8065/rec/1
6.-Amezcua ME, y cols. Lepra: pasado, presente y perspectivas para el futuro. INDRE México, 1992; pp. 15-24, 33-38, 85-97, [Publicación Técnica, 15].
7.-Nussbaum R L, Mclnnes R R, Willar D. Genética en Medicina. 8va ed. Philadelphia: Editorial Elsevier; 2016 p. 369-382.
8.-McPherson E. Genetic diagnosis and testing in clinical practice. Clin Med Res. 2006 Jun;4(2):123-9.
9.-Pagon RA. Genetic testing: when to test, when to refer. Am Fam Physician. 2005 Jul 1;72(1):33-4.
10.-Burke W. Genetic testing. N Engl J Med. 2002 Dec 5;347(23):1867-75.
11-Wolfberg AJ. Genes on the Web-direct-to-consumer marketing of genetic testing. N Engl J Med. 2006;355(6)543-5.
12.-Roche PA, Annas GJ. DNA testing, banking, and genetic privacy. N Engl J Med. 2006;355(6):545-6
13.-Fariñas Rodríguez L, Padilla Preval J, Peñalver Morales K, Rumbaut Castillo R, Brito Chávez M, Morales Peralta E. Patrones dermatoglíficos en pacientes cubanos con lepra lepromatosa. Re v Cu b a n a Ge n e t Co m u n i t. 2014;8(2):37-43
14.- Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med. 2009 Dec 31;361(27):2609-18
15.-Lagrange PH, Abel L. The genetic susceptibility to leprosy in humans. Acta Leprol 1996;10:11-27
16.-Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localization, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 2000 Dec;1(8):515-20.
17.-Schurr E, AlcaÏs A, de Léséleuc L, Abel L. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol. 2006 Dec;18(6):404-10. Epub 2006 Sep 14.
18.-Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol. 2011 [citado 4 Feb 2015];6[5]:533-49. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21585261
19.-Velarde Félix Jesús Salvador, Cázarez Salazar Silvestre Guadalupe, Castro Velázquez Rafael, Rendón Maldonado José Guadalupe, Rangel Villalobos Héctor. Association between the TaqI polymorphism of Vitamin D Receptor gene and lepromatous leprosy in a Mexican population sample. Salud pública Méx [Internet]. 2009 Feb [cited 2017 Mar 11] ; 51( 1 ): 59-61. Available from: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342009000100011&lng=en. http://dx.doi.org/10.1590/S0036-36342009000100011
20.-Leprosy in: McKusick VA. On line mendelian inheritance in man. Johns Hopkins University 2007 [citado 13 de Enero 2017]. Disponible en: http://www.ncbi.nlm.nih.gov/omim
21.-Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215.
22-Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA.
Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996 Sep 15;56(18):4108-10
23.-Seegers D, Zwiers A, Strober W, Peña AS, Bouma G. A Taq I polymorphism in the 3’UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002 Nov;3(7):419-23.
24.- General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014 Summer;81(3):14-8.
25.-Normas éticas para la protección de la información genética de ciudadanos cubanos [en línea]. Cuba: Gaceta oficial dele República de Cuba; 2007 [fecha de acceso: 6 Abril 2017]. URL disponible en: www.sld.cu/galerias/pdf/sitios/genetica/resolucion_219.
26.-Morahan G, Kaur G, Singh M, Rapthap CC, Kumar N, Katoch K, et al. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens. 2007 Apr;69 Suppl 1:234-6.
27.-Ali S, Srivastava AK,Chopra R, Aggarwal S, Garg VK, Bhattacharya SN et al. IL12B SNPs and copy number variation in IL23R gene associated with susceptibility to leprosy. J Med Genet. 2013 [citado 30 May 2015];50:34-42. Disponible en: http://jmg.bmj.com/content/50/1/34.abstract
28.-Sodsai P, Nakkuntod J, Kupatawintu P, Hirankarn N. Distribution of cytokine gene polymorphisms in Thai population. Tissue Antigens. 2011 [citado 8 May 2015];77:593-597.
29.-Lardoeyt Ferrrer Roberto. Fundamentos de genética poblacional. La Habana: Editorial Ciencias Médicas, 2016 p: 248-268.
30.-Mira M T et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature Journal of science. [Revista en la Internet].2004 Feb;427: 636-640. doi:10.1038/nature02326.[citado 2015 Ene 15]. Disponible en: http://www.nature.com/nature/journal/v427/n6975/full/nature02326.html
31.-Oliveira AL, Chaves AT, Menezes CA, Guimarães NS, Bueno LL, Fujiwara RT, Rocha MO. Vitamin D receptor expression and hepcidin levels in the protection or severity of leprosy: a systematic review. Microbes Infect. 2017 Mar;(17)30039-4
32.-Trejaut JA, Tsai ZU, Lee HL, Chen ZX. Cytokine gene polymorphisms in Taiwan. Tissue Antigens. 2004 [citado 8 May 2015];64:492-499.
Download PDF
